AzTrials
AzTrials

Carious TeethEarly Phase 1NCT07303010

The Effect of Cryotherapy on Treatment Outcomes for Pulpotomy

A Early Phase 1 study testing Addition of Cryotherapy on pulpotomy in people with Carious Teeth, run by Sirawut Hiran-us at 1 site in Thailand.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to investigate the effect of cryotherapy on treatment outcome for pulpotomny in permanent mature carious posterior teeth. The main question is: Do cryotherapy improve treatment outcome in interested samples? [primary hypothesis or outcome measure 1] Treatment outcome by clinical and… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Carious Teeth
What is being tested?
Addition of Cryotherapy on pulpotomy
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteThailand
Study dates
30 Dec 2025to 30 Dec 2035
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent posterior teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using Electric Pulp Test(EPT) and cold test. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013).
  • Teeth are restorable with direct composite restoration.

Who cannot join

  • Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
  • Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
  • Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
  • Known allergies to non-steroidal anti-inflammatory drugs (NSAIDs).
  • Pregnant or lactating patients.
  • Teeth with pulpal obliteration.
  • Necrotic pulp is found after access opening.
  • Bleed cannot be stopped within 8 minutes after full pulpotomy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sirawut Hiran-us, DDS, MSc, High Grad Dip, FRCDS contact

66 812055775

sirawut.h@chula.ac.th

Sawat Pojlerdarun, DDS, Higher Grad Dip, FRCDS contact

66 828955635

lookbadz@hotmail.com

Thailand1 site
  • Yala Hospital

    Yala, 95000

    Sawat Pojlerdarun, DDS, Higher Grad Dip, FRCDS, 66 828955635, lookbadz@hotmail.com

    Sawat Pojlerdarun, DDS, Higher Grad Dip, FRCDS

Other trials in Thailand

About this study

Official title: The Effect of Cryotherapy on Treatment Outcomes for Pulpotomy in Permanent Mature Carious Posterior Teeth: A Randomized Controlled Trial

The goal of this clinical trial is to investigate the effect of cryotherapy on treatment outcome for pulpotomny in permanent mature carious posterior teeth. The main question is: Do cryotherapy improve treatment outcome in interested samples?

[primary hypothesis or outcome measure 1] Treatment outcome by clinical and radiographic examination.

Treatment outcome from different groups will be compared at designated time points.

Read the detailed description

Materials and methods Study design and setting This study is a prospective, single-center, double-blinded, parallel-group, randomized controlled trial conducted at the Dental Department, Yala Hospital. All clinical procedures are performed by a single trained operator. Clinical outcome evaluations are carried out by the same operator, while radiographic outcome evaluations are conducted by an experienced endodontist. To maintain blinding during periapical evaluation, the crown of each tooth is masked.

Study participants Inclusion Criteria

  • Healthy patients aged at least 18 years old with deep or extremely deep carious lesions in mature permanent posterior teeth diagnose with asymptomatic or symptomatic irreversible pulpitis. Diagnoses are confirmed using Electric Pulp Test(EPT) and cold test. Pulpal and periapical diagnoses are based on terminology from the American Association of Endodontists (AAE, 2013).
  • Teeth are restorable with direct composite restoration. Exclusion Criteria
  • Teeth with subgingival caries and/or clinical attachment loss more than 3 mm and probing depth more than 4 mm.
  • Negative responses to pulp sensibility tests, presence of sinus tracts, swelling, non-restorable crowns, immature roots, or no pulp exposure following complete caries removal in case of pre-operative diagnosis as asymptomatic irreversible pulpitis.
  • Patients with systemic diseases involving bleeding disorders such as hemophilia, Von Willebrand disease, platelet disorders. And patients under taking all kind of anticoagulant and anti-platelet.
  • Known allergies to non-steroidal anti-inflammatory drugs (NSAIDs).
  • Pregnant or lactating patients.
  • Teeth with pulpal obliteration.
  • Necrotic pulp is found after access opening.
  • Bleed cannot be stopped within 8 minutes after full pulpotomy26,27 Treatment procedure A comprehensive medical and dental history is taken before treatment. Preoperative data, including age, sex and tooth number are recorded in a predesigned patient's chart. The treatment, the study design, alternative treatment modalities, potential benefits, risks, and follow-up protocol are explained to the qualifying patients and informed consent is obtained from the voluntary patients who are willing to participate in the study.

Sample size calculation The sample size was calculated based on a suspected difference of 25% in the success rate between the control and cryotherapy group in inferior alveolar nerve block35 using n4Studies with a 80% power, a 5% α error. The minimum sample size was calculated to be 122. Considering patients lost to follow-up, a total of 140 teeth from different patients are included in this study.

Randomization and masking Block randomization with variable 4 block sizes is used to generate a sequence of random numbers for allocating the patients equally into two study groups. Each random blocks are sealed in an opaque envelope which is opened at the beginning of the clinical trial by dental assistant who the one only know the intervention and prepare the intervention for operator. New block will be open after all the patient in the previous block was completed and repeat until the end of the clinical trials to ensure the equality of group distribution: The VTP with and without cryotherapy intervention groups.

Intervention

All the treatment is carried out by a single operator under magnification(3x loupes) and illumination. All the patients received a topical anesthesia before local anesthesia. An inferior alveolar nerve block (1.8 ml 2% Lidocaine with epinephrine 1:100,000) + buccal infiltration (1.7 ml 4% Articaine with epinephrine 1:100,000) for mandibular teeth, buccal infiltration (1.8 ml 2% Lidocaine with epinephrine 1:100,000) for maxillary teeth. The anesthesia is confirmed by negative response to EPT. The pulpotomy procedure is performed under rubber dam isolation in a single visit. If the patient experienced pain during the procedure, an additional anesthesia is used to achieve profound pulpal anesthesia by intraligament injection with 0.3 ml 2% Lidocaine with epinephrine 1:100,000. The operating field is disinfected with iodine and alcohol. A cylindrical diamond airotor operates under air water coolant to outline the cavity. Low speed round steel bur and a spoon excavator are used to remove the soft carious dentine using nonselective caries removal from the periphery towards the centre of the carious lesion. The deepest layer of carious dentine is thereafter disinfected with 2 ml of 2.5% NaOCl prior to pulpal exposure. The new high-speed sterile diamond airotor is used to completely remove the coronal pulp tissue. Then rinse with of 2.5% NaOCl solution up to 8 minutes to arrest the bleeding. The time to achieve hemostasis is recorded in minutes and seconds. The diagnosis of vital inflamed pulp is confirmed by the presence of bleeding in the pulp chamber. The dental assistant will bring an insulated syringe containing different intervention as follow:

Group I (Cryotherapy): After hemostasis is achieved, the pulpotomy area is irrigated for 5 minutes with normal saline solution, which is kept in the refrigerator set to 2.5°C (measuring with thermometer) by using a disposable insulated 5 ml syringe and 21-gauge needle is placed 1-2 mm above the root canal orifices and is constantly moved in a circular motion: 5 ml in each of 4 syringes, administered every 1.25 minutes per syringe.

Group II (Control): After hemostasis is achieved, the pulpotomy area is irrigated for 5 minutes with normal saline solution, which is kept in the room temperature 25°C (measuring with thermometer) by using a disposable insulated 5 ml syringe and 21-gauge needle is placed 1-2 mm above the root canal orifices and is constantly moved in a circular motion.

In both study groups, 2 mm calcium silicate cement putty type (TFRRM) is placed as a capping agent over the residual pulp. The tooth is restored with Resin Modified Glass Ionomer Cement (RMGIC) base (Vitrebond, 3M) and composite restoration (Z350XT, 3M) and polishing in the same visit.

The full pulpotomy cases where bleeding from residual pulp cannot be arrested within 8 minutes, are excluded from the study, and pulpectomy are performed. Immediate post-operative periapical radiograph is taken.

Outcome assessment All the teeth are assessed clinically at 6 months and every year and radiographs are taken. Clinically asymptomatic teeth without any radiographic evidence of periapical rarefaction or root resorption are categorized as success in strict criteria and categorized as survival in loose criteria when clinically asymptomatic teeth with periapical rarefaction14.

Recall Clinical evaluation and periapical radiograph will be taken. The quality of the coronal restoration is checked, and the restorations are repaired if deemed necessary. In case of failed cased, the cause of failure will be identified and recorded. Proper treatment will be proposed for specific problem.

All clinical evaluation will be evaluated by the same operator who is blinded from the intervention. Clinical evaluation included

  • Coronal restoration
  • EPT
  • Percussion
  • Palpation
  • Mobility
  • Probing depth
  • Occlusion Radiographic evaluation included
  • Periapical radiograph The same operator will judge the quality of the recall radiograph which include
  • 3x3 mm area covered the periapical area
  • No distortion or blurred
  • The image is able to interpret the periapical tissue

The blinded experienced endodontist will be evaluate the radiographic success of recall radiograph by recording as:

  • Normal periapical tissue
  • Thickening PDL space
  • Periapical lesion
Conditions
Carious Teeth
Being tested
Addition of Cryotherapy on pulpotomy
Keywords
pulpotomy, cryotherapy
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Addition of Cryotherapy on pulpotomyOther

    Experimental: Addition of Cryotherapy on pulpotomy After hemostasis is achieved, the pulpotomy area is irrigated for 5 minutes with normal saline solution, which is kept in the refrigerator set to 2.5°C (measuring with thermometer and record) by using a disposable insulated 5 ml syringe and 21-gauge needle is placed 1-2 mm above the root canal orifices and is constantly moved in a circular motion: 5 ml in each of 4 syringes, administered every 1.25 minutes per syringe.

Study groups in NCT07303010
Study groupRoleWhat they receive
Addition of Cryotherapy on pulpotomyExperimentalExperimental: Addition of Cryotherapy on pulpotomy After hemostasis is achieved, the pulpotomy area is irrigated for 5 minutes with normal saline solution, which is kept in the refrigerator set to 2.5°C (measuring with thermometer and record) by using a disposable insulated 5 ml syringe and 21-gauge needle is placed 1-2 mm above the root canal orifices and is constantly moved in a circular motion: 5 ml in each of 4 syringes, administered every 1.25 minutes per syringe.
Receives: Other: Addition of Cryotherapy on pulpotomy
Rountine pulpotomyNo interventionNo Intervention: Rountine pulpotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment outcome of pulpotomy

    Determine the treatment outcome in to success or failure

    Success: No clinical sign and symptom and no abnormality of periapical tissue from radiograph

    Failure: Presence of any clinical sign or symptom or abnormality of periapical tissue from radiograph

    Measured: The outcomes will be evaluated as healed, healing or disease at one year after completion of treatment and annually thereafter for up to ten years, or until the patient is no longer available for follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start30 Dec 2025 (estimated)
  3. Primary completion30 Dec 2035 (estimated)
  4. Study completion30 Dec 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07303010
Sponsor's protocol ID
BBC 33/2025
Status last verified
Dec 2025
First submitted
6 Dec 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Taha NA, Albakri SW. Outcome and Prognostic Factors for Partial and Full Pulpotomy in the Management of Spontaneous Symptomatic Pulpitis in Carious Mature Permanent Teeth: A Randomized Clinical Trial. J Endod. 2024 Jul;50(7):889-898. doi: 10.1016/j.joen.2024.03.012. Epub 2024 Apr 5.

    PubMed 38583758

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Addition of Cryotherapy on pulpotomy in people with Carious Teeth, run by Sirawut Hiran-us at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sirawut Hiran-us, DDS, MSc, High Grad Dip, FRCDS (66 812055775, sirawut.h@chula.ac.th), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment outcome of pulpotomy (time frame: The outcomes will be evaluated as healed, healing or disease at one year after completion of treatment and annually thereafter for up to ten years, or until the patient is no longer available for follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07303010, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in